A clinical trial is any research study that evaluates interventions to prevent, detect, diagnose, or treat a disease or disorder. In a clinical trial, human participants (or groups of participants) are assigned to one or more interventions to assess the results on health outcomes.
Clinical Trials are important in discovering new treatments to prevent, detect, diagnose, or treat narcolepsy. It is the only process to bring new pharmacological drugs and treatments forward for approval to use within the narcolepsy community. Without the clinical trials, there is a risk that individuals could be given treatments which have no advantage, waste time, and could even be harmful to one’s health. If a treatment has no benefit, or has serious side effects, the treatment may not be further developed.
The Behavioral Sleep Medicine Lab is researching behavioral (non-medication) treatment for nightmares in adults who have narcolepsy.
The RaiseUp Study and SunUp Study are currently enrolling adults 18 to 70 years of age who have narcolepsy and experience excessive daytime sleepiness.
Falling asleep during the day? Sudden muscle weakness? WUN is collaborating with Axsome Therapeutics on a study to assess the efficacy and safety of AXS-12 (Reboxetine) in patients with narcolepsy (SYMPHONY)
Find out how you and other people with narcolepsy may benefit from the outcome of the POLARIS studies.
There is a new clinical trial opportunity for PWNs located in Canada.
SUVN‑G3031 study: Clinical Trial Listing
Do you have excessive daytime sleepiness from narcolepsy? You may be interested to learn about SUVN-G3031, a research study evaluating an investigational product for narcolepsy with and without cataplexy.
The Behavioral Sleep Medicine Lab is researching how family members are affected by idiopathic hypersomnia (IH) and narcolepsy.
Validation of Pediatric Narcolepsy Patient Reported Outcomes (PN-PROS)
Scaling-out Better Nights, Better Days to help children and families go from surviving to thriving during COVID-19.
Please help us improve the clinical trial for patients.
WUN is collaborating with Hypersomnia Foundation and Dr. Thanh Dang-Vu to investigate brain regions underlying narcolepsy (with or without cataplexy) and idiopathic hypersomnia.